BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4847123)

  • 1. Middle-sized ninhydrin-positive molecules in uraemic patients treated by repeated haemodialysis. I. Preliminary characteristics.
    Hanicki Z; Sarnecka-Keller M; Klein A; Slizowska K
    Clin Chim Acta; 1974 Jul; 54(1):47-54. PubMed ID: 4847123
    [No Abstract]   [Full Text] [Related]  

  • 2. Middle-sized ninhydrin-positive molecules in uraemic patients treated by repeated haemodialysis. II. Chief peptide constituents of the faction.
    Klein A; Sarnecka-Keller M; Hanicki Z
    Clin Chim Acta; 1978 Nov; 90(1):7-11. PubMed ID: 719891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal lipoprotein in uraemic patients treated conservatively and by maintenance haemodialysis.
    Alam SM; Bhatt AK
    J Assoc Physicians India; 1991 Feb; 39(2):170-1. PubMed ID: 1885478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of haemostasis in fifteen uraemic patients subjected to chronic haemodialysis (author's transl)].
    Barrantes Boulanger A; Soto Quirós M; Salas González R
    Sangre (Barc); 1980; 25(3):289-99. PubMed ID: 7414445
    [No Abstract]   [Full Text] [Related]  

  • 5. Bleeding in renal failure: altered platelet function in chronic uraemia only partially corrected by haemodialysis.
    Remuzzi G; Livio M; Marchiaro G; Mecca G; de Gaetano G
    Nephron; 1978; 22(4-6):347-53. PubMed ID: 740096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum beta-endorphin in non-dialysed and haemodialysed patients with chronic renal failure.
    Trelewicz P; Grzeszczak W; Drabczyk R
    Int Urol Nephrol; 1994; 26(1):117-23. PubMed ID: 8026916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigations on clinico-chemical correlations in uraemic polyneuritis.
    Man NK; Cueuille G; Zingraff J; Drueke T; Jungers P; Sausse A; Billon JP; Funck-Brentano JL
    Proc Eur Dial Transplant Assoc; 1975; 11():214-21. PubMed ID: 1197256
    [No Abstract]   [Full Text] [Related]  

  • 8. [Retention of medium sized molecules in uremic serum].
    Dall'aglio P; Buzio C; Cambi V; Arisi L; Migone L
    Proc Eur Dial Transplant Assoc; 1972; 9():409-16. PubMed ID: 4668919
    [No Abstract]   [Full Text] [Related]  

  • 9. Removal of uraemic retention solutes in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis.
    Basile C; Libutti P; Di Turo AL; Casino FG; Vernaglione L; Tundo S; Maselli P; De Nicolò EV; Ceci E; Teutonico A; Lomonte C
    Nephrol Dial Transplant; 2011 Apr; 26(4):1296-303. PubMed ID: 20813765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some findings in patients with uraemic stomatitis.
    Hovinga J; Roodvoets AP; Gaillard J
    J Maxillofac Surg; 1975 Jun; 3(2):125-7. PubMed ID: 1055769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood level of middle molecular substances during uraemia and haemodialysis.
    Dzúrik R; Bozek P; Reznícek J; Oborníková A
    Proc Eur Dial Transplant Assoc; 1973; 10(0):263-70. PubMed ID: 4802412
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma-myoinositol concentrations in uraemic neuropathy.
    Reznek RH; Salway JG; Thomas PK
    Lancet; 1977 Mar; 1(8013):675-6. PubMed ID: 66475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does PTH influence leptin concentration in haemodialysed uraemic patients?
    Kokot F; Chudek J; Karkoszka H; Adamczak M; Wiecek A; Klimek D
    Nephron; 1999; 82(4):372-3. PubMed ID: 10450049
    [No Abstract]   [Full Text] [Related]  

  • 14. The Case | Rapidly progressing polyneuropathy in a dialysis patient.
    Chen T; Cleland B; Nankivell BJ
    Kidney Int; 2016 Jun; 89(6):1409-10. PubMed ID: 27181789
    [No Abstract]   [Full Text] [Related]  

  • 15. beta 2-Microglobulin and other low molecular weight proteins in haemodiafiltrates and in haemofiltrates.
    Montali U; Pilone N; Cioni L; Ronca G
    Int J Tissue React; 1984; 6(1):71-4. PubMed ID: 6370888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble CD40 in the serum of healthy donors, patients with chronic renal failure, haemodialysis and chronic ambulatory peritoneal dialysis (CAPD) patients.
    Schwabe RF; Engelmann H; Hess S; Fricke H
    Clin Exp Immunol; 1999 Jul; 117(1):153-8. PubMed ID: 10403929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein damage and inflammation in uraemia and dialysis patients.
    Galli F
    Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v20-36. PubMed ID: 17586842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The so-called "onion-like shape thromboelastogram" in dialyzed uraemic patients.
    Suchecki T
    Thromb Diath Haemorrh; 1974 Jun; 31(3):513-6. PubMed ID: 4424222
    [No Abstract]   [Full Text] [Related]  

  • 19. Red blood cell volume distribution width (RDW) in uraemic patients on chronic haemodialysis.
    Docci D; Delvecchio C; Gollini C; Turci F; Baldrati L; Gilli P
    Int J Artif Organs; 1989 Mar; 12(3):170-4. PubMed ID: 2744877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2.
    Fernández-Fresnedo G; Ramos MA; González-Pardo MC; de Francisco AL; López-Hoyos M; Arias M
    Nephrol Dial Transplant; 2000 Apr; 15(4):502-10. PubMed ID: 10727545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.